MCM
NTLA icon

MV Capital Management’s Intellia Therapeutics NTLA Stock Holding History

MV Capital Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$693 Hold
54
– – ﹤0.01% 922
2025
Q4 		$486 Hold
54
– – ﹤0.01% 921
2025
Q3 		$933 Hold
54
– – ﹤0.01% 798
2025
Q2 		$507 Buy
54
+3
+6% +$25 ﹤0.01% 844
2025
Q1 		$363 Sell
51
-37
-42% -$374 ﹤0.01% 852
2024
Q4 		$1.03K Buy
88
+65
+283% +$1.01K ﹤0.01% 747
2024
Q3 		$473 Buy
23
+18
+360% +$415 ﹤0.01% 811
2024
Q2 		$112 Sell
5
-1
-17% -$24 ﹤0.01% 879
2024
Q1 		$166 Buy
+6
New +$167 ﹤0.01% 739

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return